Tirzepatide emerges a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://alberthbvm355499.kylieblog.com/41092033/tirzepatide-a-game-changer-for-type-2-diabetes